HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yasuo Ikeda Selected Research
Yasuo Ikeda Research Topics
Disease
25
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
12/2015 - 04/2002
23
Hemorrhage
10/2021 - 05/2002
22
Neoplasms (Cancer)
04/2018 - 07/2003
22
Thrombosis (Thrombus)
04/2018 - 01/2002
22
Multiple Myeloma
12/2014 - 04/2002
17
Thrombocytopenia (Thrombopenia)
11/2015 - 05/2002
11
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2011 - 06/2002
10
Stroke (Strokes)
02/2021 - 12/2006
9
Ischemic Stroke
02/2021 - 12/2006
9
Myocardial Infarction
01/2020 - 12/2004
9
Infections
01/2019 - 01/2002
8
Hypertension (High Blood Pressure)
01/2021 - 01/2004
8
Leukemia
03/2007 - 01/2002
7
Body Weight (Weight, Body)
01/2020 - 05/2002
7
Acute Coronary Syndrome
01/2020 - 01/2009
7
Diabetes Mellitus
04/2018 - 01/2004
6
Autoimmune Diseases (Autoimmune Disease)
12/2015 - 08/2003
6
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2014 - 06/2002
6
Venous Thrombosis (Deep-Vein Thrombosis)
05/2009 - 03/2002
5
Aplastic Anemia (Anemia, Hypoplastic)
01/2014 - 02/2003
5
Sepsis (Septicemia)
06/2011 - 04/2003
5
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2009 - 06/2002
5
Hematologic Neoplasms (Hematological Malignancy)
12/2008 - 08/2002
5
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2008 - 06/2002
5
Acute Promyelocytic Leukemia
03/2005 - 01/2002
4
Cardiovascular Diseases (Cardiovascular Disease)
02/2020 - 05/2014
4
Embolic Stroke
01/2020 - 04/2018
4
Dyslipidemias (Dyslipidemia)
01/2019 - 03/2010
4
Vascular System Injuries
04/2010 - 01/2004
4
Chromosome Aberrations (Chromosome Abnormalities)
06/2008 - 02/2003
4
Anemia
09/2005 - 04/2002
4
Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
02/2005 - 04/2002
3
Transient Ischemic Attack
01/2016 - 12/2006
3
Coronary Artery Disease (Coronary Atherosclerosis)
01/2014 - 12/2011
3
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2014 - 08/2002
3
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2010 - 09/2005
3
Connective Tissue Diseases (Connective Tissue Disease)
01/2009 - 10/2004
3
Heart Failure
01/2009 - 01/2003
3
Dermatomyositis (Dermatopolymyositis)
01/2009 - 05/2005
3
Stomatitis
12/2008 - 04/2005
3
Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
03/2008 - 10/2005
3
Eosinophilia
09/2007 - 09/2004
3
Central Nervous System Diseases (CNS Diseases)
01/2007 - 10/2002
3
Myeloid Leukemia (Leukemia, Myelocytic)
10/2006 - 07/2002
3
Pneumonia (Pneumonitis)
01/2006 - 09/2004
3
Cytopenia
09/2005 - 09/2003
3
Leukopenia
09/2005 - 09/2004
Drug/Important Bio-Agent (IBA)
21
Inosine Triphosphate (ITP)
IBA
12/2015 - 05/2002
18
Autoantibodies
IBA
12/2015 - 04/2002
15
Clopidogrel (Plavix)
FDA Link
02/2021 - 01/2008
14
Prasugrel Hydrochloride
FDA Link
02/2021 - 05/2012
13
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
02/2020 - 01/2007
12
Imatinib Mesylate (Gleevec)
FDA Link
05/2011 - 08/2002
8
Pharmaceutical Preparations
IBA
09/2015 - 04/2004
8
Thalidomide (Thalomid)
FDA Link
10/2012 - 09/2002
8
Antibodies
IBA
09/2012 - 08/2002
8
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
06/2008 - 01/2002
7
von Willebrand Factor
IBA
03/2011 - 01/2002
6
Proteins (Proteins, Gene)
FDA Link
04/2011 - 11/2003
6
Thrombopoietin (c-mpl Ligand)
IBA
10/2008 - 08/2002
5
Platelet Aggregation Inhibitors (Antiplatelet Drugs)
IBA
01/2021 - 01/2006
5
Enzymes
IBA
01/2014 - 03/2002
5
Immunoglobulin G (IgG)
IBA
04/2012 - 01/2003
5
Messenger RNA (mRNA)
IBA
06/2011 - 01/2002
5
Collagen
IBA
03/2011 - 12/2003
5
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2009 - 05/2002
5
Cytarabine (Cytosar-U)
FDA Link
Generic
12/2008 - 01/2004
5
Monoclonal Antibodies
IBA
12/2004 - 01/2003
4
Fibrinogen (Factor I)
FDA Link
09/2015 - 07/2007
4
Liposomes (Liposome)
IBA
09/2015 - 04/2010
4
Hemostatics (Antihemorrhagics)
IBA
01/2013 - 01/2008
4
Antigens
IBA
04/2012 - 08/2002
4
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
03/2012 - 04/2002
4
Anti-Bacterial Agents (Antibiotics)
IBA
06/2011 - 09/2005
4
NF-kappa B (NF-kB)
IBA
11/2007 - 01/2005
4
Tretinoin (Retinoic Acid)
FDA Link
Generic
03/2005 - 07/2002
4
Platelet Membrane Glycoproteins
IBA
02/2005 - 01/2002
3
Purinergic P2Y Receptor Antagonists
IBA
01/2020 - 05/2012
3
N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester
IBA
04/2018 - 12/2014
3
Rituximab (Mabthera)
FDA Link
12/2015 - 09/2005
3
Adenosine Diphosphate (ADP)
IBA
09/2015 - 08/2013
3
Intravenous Immunoglobulins (IVIG)
FDA Link
01/2014 - 01/2008
3
Glycoproteins (Glycoprotein)
IBA
08/2013 - 01/2003
3
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
11/2011 - 01/2006
3
Steroids
IBA
01/2008 - 05/2002
3
Sultan
IBA
11/2007 - 07/2004
3
Caspases
IBA
11/2007 - 07/2002
3
Dexamethasone (Maxidex)
FDA Link
Generic
04/2007 - 01/2003
3
Reactive Oxygen Species (Oxygen Radicals)
IBA
10/2006 - 10/2004
3
Polyphenols
IBA
03/2006 - 03/2005
Therapy/Procedure
30
Therapeutics
01/2020 - 01/2002
11
Hematopoietic Stem Cell Transplantation
01/2014 - 04/2004
11
Transplantation
01/2008 - 06/2002
10
Drug Therapy (Chemotherapy)
05/2014 - 01/2002
8
Percutaneous Coronary Intervention
01/2020 - 05/2012
8
Stem Cell Transplantation
01/2009 - 01/2003
7
Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2006 - 06/2002
5
Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
11/2006 - 09/2005
3
Platelet Transfusion (Blood Platelet Transfusions)
01/2019 - 05/2002
3
Drug Tapering
11/2008 - 09/2002